Register entry
Institut National des Radio-Elements
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 8
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
88 active NDC listings: 5 bulk ingredient, 3 drug for further processing. By marketing category: BULK INGREDIENT 5, DRUG FOR FURTHER PROCESSING 3.
| Dosage form | NDCs |
|---|---|
| solution | 6 |
| solution, concentrate | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| institut national des radio-elements | 8 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | (Ge-68) Germanium Chloride/(Ga-68) Gallium Chloride | solution | 64805-0302BULK INGREDIENT |
| - | (Ge-68) Germanium Chloride/(Ga-68) Gallium Chloride | solution | 64805-0303BULK INGREDIENT |
| - | (Ge-68) Germanium Chloride/(Ga-68) Gallium Chloride | solution | 64805-0304BULK INGREDIENT |
| - | (Ge-68) Germanium Chloride/(Ga-68) Gallium Chloride | solution | 64805-0305BULK INGREDIENT |
| - | (Ge-68) Germanium Chloride/(Ga-68) Gallium Chloride | solution | 64805-0310BULK INGREDIENT |
| - | MOLYBDENUM MO-99 | solution | 64805-1997DRUG FOR FURTHER PROCESSING |
| - | SODIUM IODIDE I-131 | solution, concentrate | 64805-2311DRUG FOR FURTHER PROCESSING |
| - | SODIUM MOLYBDATE MO-99 | solution, concentrate | 64805-1991DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing (ge-68) germanium chloride/(ga-68) gallium chloride
- Eckert & Ziegler Radiopharma GmbH1 site · 11 NDC
Enquiry
Common questions
- Is Institut National des Radio-Elements FDA approved?
- Institut National des Radio-Elements holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Institut National des Radio-Elements make?
- 8 products are listed under Institut National des Radio-Elements in the openFDA NDC Directory, most often as solution; solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.